Nanowear is a pioneering company in the biotechnology sector that has been transforming home-based health care since its founding in 2014. The company's slogan, "Transforming home-based health care with cloth nanotechnology and AI driven remote diagnostics," encapsulates its mission to revolutionize the remote diagnostics industry. Nanowear's AI-based remote diagnostics platform is built on cloth-based nanotechnology and caters to a diverse range of markets, including cardiac, neurological, industrial safety/government, and sports medicine/performance diagnostics monitoring.
One of the standout offerings from Nanowear is its proprietary advanced materials and AI-enabled continuous and time-synchronous electrophysiological, hemodynamic, acoustic, metabolic, and activity monitoring. This innovation empowers medical professionals with scored, clinical-grade diagnostic data through a cost-effective and gender-neutral, size-adjustable undergarment called SimpleSense. The company's commitment to innovation and next-gen technologies is exemplified through its research and development centers in Berkeley, CA and University Park, PA, as well as an advanced materials production facility in Nashville, TN.
Notably, Nanowear received a grant investment from MedTech Innovator on 01 May 2017, reflecting investor confidence in the company's endeavors. As it continues to explore unique and groundbreaking applications for its nanosensors, Nanowear is positioned to make a significant impact in the field of remote diagnostics and home-based health care.